XTNT

Xtant Medical Holdings, Inc.

Insider trading activity for Xtant Medical Holdings, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 28 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Aug 15	Lipschultz Tyler	Director	AGRANT	215,517	—	—	+136.2%	Open the original filing on SEC.gov
Aug 15	Bakewell John K	Director	AGRANT	215,517	—	—	+23.6%	Open the original filing on SEC.gov
Aug 15	Beeson Jonn R.	Director	AGRANT	215,517	—	—	+41.6%	Open the original filing on SEC.gov
Aug 15	Jain Abhinav	Director	AGRANT	215,517	—	—	+136.2%	Open the original filing on SEC.gov
Aug 15	Vizirgianakis Stavros G.	Director	AGRANT	323,275	—	—	+4.3%	Open the original filing on SEC.gov
Aug 15	Schallenberger Mark A.	Chief Operating Officer	FTAX	7,070	$0.31	$2.2K	-0.6%	Open the original filing on SEC.gov
Aug 15	Schallenberger Mark A.	Chief Operating Officer	AGRANT	450,000	—	—	+67.9%	Open the original filing on SEC.gov
Aug 15	Neils Scott C	CFO and Assistant…	FTAX	28,155	$0.31	$8.7K	-2.3%	Open the original filing on SEC.gov
Aug 15	Neils Scott C	CFO and Assistant…	AGRANT	400,000	—	—	+47.4%	Open the original filing on SEC.gov
Aug 15	Browne Sean E	President and CEO	FTAX	10,605	$0.31	$3.3K	-0.3%	Open the original filing on SEC.gov
Aug 15	Browne Sean E	President and CEO	AGRANT	550,000	—	—	+21.4%	Open the original filing on SEC.gov
Feb 15	Schallenberger Mark A.	Chief Operating Officer	FTAX	7,709	$0.58	$4.5K	-1.1%	Open the original filing on SEC.gov
Jan 15	Neils Scott C	CFO and Assistant…	FTAX	8,084	$0.65	$5.3K	-0.9%	Open the original filing on SEC.gov
Nov 15, 2025	Bakewell John K	Director	AGRANT↺	158,228	—	—	+20.9%	Open the original filing on SEC.gov
Nov 15, 2025	Vizirgianakis Stavros G.	Director	AGRANT	553,797	—	—	+8.0%	Open the original filing on SEC.gov
Nov 15, 2025	Schallenberger Mark A.	Chief Operating Officer	AGRANT◆	584,506	—	—	—	Open the original filing on SEC.gov
Nov 15, 2025	Schallenberger Mark A.	Chief Operating Officer	AGRANT	292,253	—	—	+77.2%	Open the original filing on SEC.gov
Nov 15, 2025	Neils Scott C	CFO and Assistant…	AGRANT◆	526,582	—	—	—	Open the original filing on SEC.gov
Nov 15, 2025	Neils Scott C	CFO and Assistant…	AGRANT	263,291	—	—	+44.8%	Open the original filing on SEC.gov
Nov 15, 2025	Lipschultz Tyler	Director	AGRANT	158,228	—	—	—	Open the original filing on SEC.gov
Nov 15, 2025	Jain Abhinav	Director	AGRANT	158,228	—	—	—	Open the original filing on SEC.gov
Nov 15, 2025	Browne Sean E	President and CEO	AGRANT◆	789,874	—	—	—	Open the original filing on SEC.gov
Nov 15, 2025	Browne Sean E	President and CEO	AGRANT	394,937	—	—	+18.1%	Open the original filing on SEC.gov
Nov 15, 2025	Beeson Jonn R.	Director	AGRANT	158,228	—	—	+44.0%	Open the original filing on SEC.gov
Aug 15, 2025	Neils Scott C	CFO	FTAX	34,131	$0.63	$21.5K	-5.5%	Open the original filing on SEC.gov
Aug 15, 2025	Browne Sean E	President and CEO	FTAX	10,605	$0.63	$6.7K	-0.5%	Open the original filing on SEC.gov
Apr 10, 2025	Orbimed Advisors Llc	10% Owner	SSELL	17.1M	$0.42	$7.2M	-100.0%	Open the original filing on SEC.gov
Apr 10, 2025	Orbimed Advisors Llc	10% Owner	SSELL	56M	$0.42	$23.5M	-100.0%	Open the original filing on SEC.gov

AGRANT—

Lipschultz Tyler · DirectorAug 15

215,517 sh · +136.2% own

AGRANT—

Bakewell John K · DirectorAug 15

215,517 sh · +23.6% own

AGRANT—

Beeson Jonn R. · DirectorAug 15

215,517 sh · +41.6% own

AGRANT—

Jain Abhinav · DirectorAug 15

215,517 sh · +136.2% own

AGRANT—

Vizirgianakis Stavros G. · DirectorAug 15

323,275 sh · +4.3% own

FTAX$2.2K

Schallenberger Mark A. · Chief Operating…Aug 15

7,070 sh @ $0.31 · -0.6% own

AGRANT—

Schallenberger Mark A. · Chief Operating…Aug 15

450,000 sh · +67.9% own

FTAX$8.7K

Neils Scott C · CFO and Assistant…Aug 15

28,155 sh @ $0.31 · -2.3% own

AGRANT—

Neils Scott C · CFO and Assistant…Aug 15

400,000 sh · +47.4% own

FTAX$3.3K

Browne Sean E · President and CEOAug 15

10,605 sh @ $0.31 · -0.3% own

AGRANT—

Browne Sean E · President and CEOAug 15

550,000 sh · +21.4% own

FTAX$4.5K

Schallenberger Mark A. · Chief Operating…Feb 15

7,709 sh @ $0.58 · -1.1% own

FTAX$5.3K

Neils Scott C · CFO and Assistant…Jan 15

8,084 sh @ $0.65 · -0.9% own

AGRANT↺—

Bakewell John K · DirectorNov 15, 2025

158,228 sh · +20.9% own

AGRANT—

Vizirgianakis Stavros G. · DirectorNov 15, 2025

553,797 sh · +8.0% own

AGRANT◆—

Schallenberger Mark A. · Chief Operating…Nov 15, 2025

584,506 sh

AGRANT—

Schallenberger Mark A. · Chief Operating…Nov 15, 2025

292,253 sh · +77.2% own

AGRANT◆—

Neils Scott C · CFO and Assistant…Nov 15, 2025

526,582 sh

AGRANT—

Neils Scott C · CFO and Assistant…Nov 15, 2025

263,291 sh · +44.8% own

AGRANT—

Lipschultz Tyler · DirectorNov 15, 2025

158,228 sh

AGRANT—

Jain Abhinav · DirectorNov 15, 2025

158,228 sh

AGRANT◆—

Browne Sean E · President and CEONov 15, 2025

789,874 sh

AGRANT—

Browne Sean E · President and CEONov 15, 2025

394,937 sh · +18.1% own

AGRANT—

Beeson Jonn R. · DirectorNov 15, 2025

158,228 sh · +44.0% own

FTAX$21.5K

Neils Scott C · CFOAug 15, 2025

34,131 sh @ $0.63 · -5.5% own

FTAX$6.7K

Browne Sean E · President and CEOAug 15, 2025

10,605 sh @ $0.63 · -0.5% own

SSELL$7.2M

Orbimed Advisors Llc · 10% OwnerApr 10, 2025

17.1M sh @ $0.42 · -100.0% own

SSELL$23.5M

Orbimed Advisors Llc · 10% OwnerApr 10, 2025

56M sh @ $0.42 · -100.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 20 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →